Literature DB >> 7690328

Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome.

A Durandy1, C Schiff, J Y Bonnefoy, M Forveille, F Rousset, G Mazzei, M Milili, A Fischer.   

Abstract

We studied the ability of B lymphocytes from patients with X-linked hyper IgM syndrome (HIGM1) to be activated via the CD40 membrane receptor. HIGM1 is caused by a CD40 ligand gene mutation, leading to defective expression on the membrane of activated T lymphocytes. We found that triggering of B cells by an anti-CD40 monoclonal antibody or the soluble CD40 ligand plus interleukin (IL)-4 or IL-10 led to B cell proliferation and/or differentiation towards IgG, IgA and IgE secretion. This was reflected by transcription of C gamma, alpha and epsilon membrane isotype expression and IgG, IgA and IgE production. These results confirm the integrity of B cells in patients with the HIGM1 immunodeficiency and open up new therapeutic possibilities.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690328     DOI: 10.1002/eji.1830230936

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  19 in total

1.  Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.

Authors:  Laurence M Howard; Serge Ostrovidov; Cassandra E Smith; Mauro C Dal Canto; Stephen D Miller
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

2.  Immunodeficiencies due to defects of class-switch recombination.

Authors:  Luigi D Notarangelo; Gaetana Lanzi; Paola Toniati; Silvia Giliani
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.

Authors:  A Bhushan; L R Covey
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 4.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

5.  Class switch recombination in selective IgA-deficient subjects.

Authors:  L Hummelshoj; L P Ryder; L K Nielsen; C H Nielsen; L K Poulsen
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

6.  Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.

Authors:  J Bajorath; K Seyama; S Nonoyama; H D Ochs; A Aruffo
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

7.  A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line.

Authors:  Mario I Vega; Leopoldo Santos-Argumedo; Sara Huerta-Yepez; Rosendo Luría-Perez; Vianney Ortiz-Navarrete; Armado Isibasi; Cesar R González-Bonilla
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

8.  Absence of IgD-CD27(+) memory B cell population in X-linked hyper-IgM syndrome.

Authors:  K Agematsu; H Nagumo; K Shinozaki; S Hokibara; K Yasui; K Terada; N Kawamura; T Toba; S Nonoyama; H D Ochs; A Komiyama
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Intrinsic defect in B cells of patients with hyper-immunoglobulin M syndrome.

Authors:  Y B Porat; D Levy; J Levy; I Zan-Bar
Journal:  Clin Diagn Lab Immunol       Date:  1995-07

10.  Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region.

Authors:  Jennifer Laughlin; Sanaz Oghlidos; Joseph F Porter; Rodrigo Matus-Nicodemos; Frank L Sinquett; Valentina Marcelli; Lori R Covey
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.